Author | James K. McCloskey II, MD | OncLive

Author | James K. McCloskey II, MD

Articles

Dr. McCloskey on the Results of the ASCERTAIN Trial in MDS

January 08, 2020

Video

James K. McCloskey II, MD, discusses the results of the phase III ASCERTAIN trial in myelodysplastic syndrome.

Dr. McCloskey Discusses IDH Inhibitors in AML

February 14, 2018

Video

James K. McCloskey II, MD, medical oncologist, Division of Leukemia and the Adult Blood and Marrow Stem Cell Transplantation Program, John Theurer Cancer Center, discusses IDH inhibitors in acute lymphoblastic leukemia (AML).

Dr. McCloskey Discusses Targeting CD19 in B-Cell ALL

December 22, 2017

Video

James K. McCloskey II, MD, medical oncologist, Division of Leukemia and the Adult Blood and Marrow Stem Cell Transplantation Program, John Theurer Cancer Center, discusses targeting CD19 in patients with acute lymphocytic leukemia.

Pacritinib May Offer New Option for Tackling Myelofibrosis in Patients With Cytopenias

February 03, 2016

Article

Pacritinib, a JAK2/FLT3 inhibitor, is among the most promising of those emerging options for patients with myelofibrosis.

x